If it continues, GERD can cause scarring and narrowing of the esophagus and increase a persons risk of esophageal cancer.Results show that people taking GLP-1 drugs were 27% more likely to develop GERD and 55% more likely to have GERD complications, when compared to people taking SGLT-2 inhibitors.More than 90% of GERD complications involved Barrett esophagus, in which acid damage changes the tissue lining of the esophagus and increases cancer risk, researchers noted.We also found that the risk for GERD was higher with long-acting GLP-1 (drug) use, researchers wrote.However, they noted that these findings need to be verified by studies involving other groups, including those taking GLP-1 drugs for obesity.There is limited evidence on the risk for GERD among patients with obesity who do not have type 2 diabetes, researchers wrote

In terms of key secondary outcomes, mean changes from baseline in body weight at week 26 were -1.2 kg, -2.2 kg, and -3.1 kg for semaglutide 3 mg, 7 mg, and 14 mg, respectively
For example, the monthly cost of Ozempic, the diabetes version of semaglutide, ranges from $83 to $144 in Europe, compared to $936 in the U.S
309 , R795R804 (2015)
By enhancing detoxification, you can optimize glutathione function
This means you get only the nutrients your body needsnothing more, nothing less